article thumbnail

Patient-Centric Marketing in the Life Science Industry: Putting the Focus on Patient Needs

Pharma Mirror

by Nataliya Andreychuk, Co-founder and CEO of Viseven Many pharma brands still shy away from marketing directly to patients, depending on conversion through healthcare providers (HCPs). And it is not hard to see why.

article thumbnail

Will the excitement for Threads translate to life sciences brands?

pharmaphorum

Will the excitement for Threads translate to life sciences brands? Mike.Hammerton Thu, 12/10/2023 - 10:00 Bookmark this

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Verix boosts life science AI capabilities with start-up.ai acquisition

Pharmaceutical Technology

for an undisclosed sum, boosting its life science AI capabilities. The deal enables Verix to further improve its capacities to use AI to advance the brand growth of life science companies. Artificial intelligence (AI)-driven commercial optimisation platform provider Verix has purchased start-up.ai start-up.ai

article thumbnail

The mysterious UK Life Sciences Council

pharmaphorum

Life Sciences Council. Do you know about the Life Sciences Council (LSC)? The LSC has a website on Gov.uk, but the page says Life Sciences Council. A post from the director of health and life sciences at Innovate UK, Richard J Hebdon, also bigged up the news before the Council met about four health missions.

article thumbnail

Reaching New Global ‘Frontiers’ In Life Sciences

Intouch Solutions

The annual event assembled nearly 1,000 attendees from over 40+ countries across the healthcare ecosystem to learn, network and explore industry challenges, strategic trends and solutions in life sciences and healthcare.

article thumbnail

Cytiva and Pall Life Sciences complete integration

Drug Discovery World

Cytiva and the life sciences business of Pall Corporation have completed their integration and are now united as one business under the Cytiva brand. In January 2023, the life sciences business of Pall separated from Pall Corporation. The Pall medical portfolio will remain a market brand and part of Cytiva.

article thumbnail

PerkinElmer separates Life Sciences and Diagnostics business

Drug Discovery World

The resulting new Life Sciences and Diagnostics business will share the PerkinElmer name until a new name, brand and ticker symbol is unveiled in Q2 2023 pending shareholder approval. I’m looking forward to sharing our new name and brand in the near future.”